Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic mice
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic mice
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 132, Issue 6, Pages 1451-1462
Publisher
Wiley
Online
2012-08-13
DOI
10.1002/ijc.27770
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Viral hepatocarcinogenesis: from infection to cancer
- (2010) Alexander Tan et al. LIVER INTERNATIONAL
- Selectivity of Oncolytic Viral Replication Prevents Antiviral Immune Response and Toxicity, but Does Not Improve Antitumoral Immunity
- (2010) Engin Gürlevik et al. MOLECULAR THERAPY
- Antitumoral Immune Response by Recruitment and Expansion of Dendritic Cells in Tumors Infected with Telomerase-Dependent Oncolytic Viruses
- (2009) Edukulla Ramakrishna et al. CANCER RESEARCH
- Novel Immunocompetent Murine Tumor Model for Evaluation of Conditionally Replication-Competent (Oncolytic) Murine Adenoviral Vectors
- (2009) M. Robinson et al. JOURNAL OF VIROLOGY
- A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors
- (2009) John Nemunaitis et al. MOLECULAR THERAPY
- Current management strategy of hepatocellular carcinoma
- (2009) Bernardino Rampone et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Direct and distant antitumor effects of a telomerase-selective oncolytic adenoviral agent, OBP-301, in a mouse prostate cancer model
- (2008) P Huang et al. CANCER GENE THERAPY
- Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer
- (2008) Simon N. Waddington et al. CELL
- Molecular targeted therapies in hepatocellular carcinoma
- (2008) Josep M. Llovet et al. HEPATOLOGY
- Combination of oncolytic adenovirotherapy and Bax gene therapy in human cancer xenografted models. Potential merits and hurdles for combination therapy
- (2008) Masayoshi Hioki et al. INTERNATIONAL JOURNAL OF CANCER
- Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
- (2008) Byeong-Ho Park et al. LANCET ONCOLOGY
- The Targeted Oncolytic Poxvirus JX-594 Demonstrates Antitumoral, Antivascular, and Anti-HBV Activities in Patients With Hepatocellular Carcinoma
- (2008) Ta-Chiang Liu et al. MOLECULAR THERAPY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo
- (2008) O. Kalyuzhniy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Telomerase-specifi c oncolytic virotherapy for human hepatocellular carcinoma
- (2008) Yue-Min Li et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Treatment options for hepatocellular carcinoma
- (2008) Dalbir S Sandhu et al. Expert Review of Gastroenterology & Hepatology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started